Position in GMAB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$58,615,523
+$2,114,804 QoQ
Shares Held
2,184,701
+19.1% QoQ
Ownership
0.356%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 80.52337596769536.ToString("F0")%
Shared 0.ToString("F0")%
None 19.47662403230465.ToString("F0")%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. GMAB ranks #49 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in GMAB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $58,615,523 | 2,184,701 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $56,500,719 | 1,834,439 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $51,359,180 | 1,674,574 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $55,722,803 | 2,697,135 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $55,586,205 | 2,838,928 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $58,558,731 | 2,805,881 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $39,992,705 | 1,640,390 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $25,868,240 | 1,029,377 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $29,133,413 | 974,036 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $34,676,845 | 1,089,097 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $38,815,302 | 1,100,519 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $38,347,525 | 1,008,880 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $40,652,111 | 1,076,592 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $51,528,187 | 1,215,861 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $27,890,026 | 868,037 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $23,669,123 | 728,505 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $3,820,715 | 105,603 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $5,650,510 | 142,834 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,712,349 | 176,484 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,901,109 | 242,496 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $12,019,815 | 366,123 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $21,803,598 | 536,242 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $31,505,868 | 860,581 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $43,422,611 | 1,281,281 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,690,787 | 221,368 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||